The U.S. Food and Drug Administration (FDA) has granted Visby Medical marketing authorization for its Women’s Sexual Health Test, a groundbreaking diagnostic tool that allows at-home testing ...

Soleno Therapeutics (SLNO) stock skyrocketed up over 42% this past week on news that it has achieved a significant milestone ...

Delphinus Medical Technologies and Austin Radiological Association (ARA) proudly announce the success of ARA’s SoftVue screening program, launched in December at their Cedar Park location. As the only ...

Investigate the science behind red light therapy and its effects on skin rejuvenation, sleep quality, and muscle recovery in ...

Expecting FDA decision on marketing authorization for early-stage low risk breast cancer with endocrine therapy Positive ProSense® results were reported through 33 ...

Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.

PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors ...

A pill used in most U.S. abortions has been ensnared in politics for years, and many Americans wonder whether it will be ...

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...